← Search

Data · dataset · 2026

Investigating the role of BTKi and the histone variant macroH2A1 in chronic lymphocytic leukaemia

Listed in ZivaHub and Deakin Research Online and DMU Figshare — shown once because both records carry DOI 10.17034/32639439.v1

Chronic Lymphocytic Leukaemia (CLL) is a highly heterogeneous CD5+ lymphoproliferative disorder.

Description

Epigenetic phenomena play an important role in CLL. Bruton’s tyrosine kinase (BTK), part of the B cell receptor signalling, has been targeted therapeutically and has led to a paradigm shift in CLL treatment.

BTK inhibition by Ibrutinib has been associated with changes at the epigenetic level and shown to alter the CLL enhancer landscape.<br><br>A MACROH2A1-related Ibrutinib-responsive active region was discovered in matched pre-/post-Ibrutinib treated CLL samples by H3K27ac ChIP-seq. MacroH2A1 is a histone variant with an important role in genome stability. Additionally, integrated analysis of this ChIP-seq with RNA-seq data from the matched pre-/post-Ibrutinib treated CLL patient samples revealed several genes shown to be altered upon Ibrutinib.

Read the rest (1 more)

Together, patient and cell lines data suggest Ibrutinib may have an impact on macroH2A1 and its isoforms in CLL as well as other genes.<br><br>This work provides first evidence for a role of macroH2A1 and its epigenetic regulation in CLL in the context of BTK inhibitor treatment. The multifaceted role of macroH2A1 in disease, its potential as a therapeutic target and the knowledge gap in the CLL/BTK context, suggest that dissection of macroH2A1’s role on the epigenetic axis demands further investigation.<br><br><i>Thesis is embargoed until 31 July 2029</i>.<br><br><br>

Links

Where it is published

Catalogue records · 1

Topics

Inferred from text
Disease 75% · RNA sequencing 65%
Provenance · 3 source records, 19 field assertions
SourceKeyLast seenRaw
ZivaHuboai:figshare.com:article/3263943913 d agoJSON v1
Deakin Research Onlineoai:figshare.com:article/3263943913 d agoJSON v1
DMU Figshareoai:figshare.com:article/3263943913 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[disease].local:disease:cancermapping · figshare dmu ac ukvocabulary-mapper@1.0.0keywords['cancer']
concepts[disease].local:disease:cancermapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['cancer']
concepts[disease].local:disease:cancermapping · dro deakin edu auvocabulary-mapper@1.0.0keywords['cancer']
concepts[disease].local:disease:diseaseenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (75%)
concepts[field].anzsrc:field:310504mapping · dro deakin edu auvocabulary-mapper@1.0.0keywords['epigenetics']
concepts[field].anzsrc:field:310504mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['epigenetics']
concepts[field].anzsrc:field:310504mapping · figshare dmu ac ukvocabulary-mapper@1.0.0keywords['epigenetics']
concepts[field].local:field:earth-environmentalmapping · dro deakin edu auconnector:dro_deakin_edu_au@1.0.0
concepts[field].local:field:earth-environmentalmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:earth-environmentalmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
concepts[field].local:field:medicine-healthmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:medicine-healthmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
concepts[field].local:field:medicine-healthmapping · dro deakin edu auconnector:dro_deakin_edu_au@1.0.0
concepts[modality].local:modality:rna-seqenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (65%)
descriptionsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/description
license_textsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
publication_datesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
titlesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/title